Cargando…
Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
Bladder cancer is the 10th most diagnosed cancer, with almost 10 M cancer deaths last year worldwide. Currently, chemotherapy is widely used as adjuvant therapy after surgical transurethral resection. Paclitaxel (PTX) is one of the most promising drugs, but cancer cells acquire resistance, causing f...
Autores principales: | Arista-Romero, Maria, Cascante, Anna, Fornaguera, Cristina, Borrós, Salvador |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618611/ https://www.ncbi.nlm.nih.gov/pubmed/34834374 http://dx.doi.org/10.3390/pharmaceutics13111959 |
Ejemplares similares
-
Dual stimuli-responsive polyphosphazene-based molecular gates for controlled drug delivery in lung cancer cells
por: Salinas, Yolanda, et al.
Publicado: (2020) -
Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery
por: Llinàs, Maria C., et al.
Publicado: (2018) -
Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
por: García-Fernández, Coral, et al.
Publicado: (2020) -
Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses
por: Brugada-Vilà, Pau, et al.
Publicado: (2020) -
Engineering oncogene-targeted anisamide-functionalized pBAE nanoparticles as efficient lung cancer antisense therapies
por: Fornaguera, Cristina, et al.
Publicado: (2023)